Supernus Pharmaceuticals, Inc. - Common Stock — 재무제표 (NASDAQ:SUPN) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 1.5 B1.69 B1.7 B1.28 B1.37 B1.45 B 총 부채 759.24 M873.3 M816.3 M356.16 M332.34 M390.93 M 자본금 총액 744.86 M815.85 M886.2 M921.52 M1.04 B1.06 B 총 부채 및 주주자본 1.5 B1.69 B1.7 B1.28 B1.37 B1.45 B 총부채 365.51 M379.25 M401.97 M——— 순부채 -57.02 M39.57 M-59.37 M———

뉴스

Should You Buy, Sell or Hold BIIB Stock After it Rises Almost 12% YTD?

Supernus Pharmaceuticals, Inc. (SUPN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Supernus Pharmaceuticals, Inc. (SUPN) Q1 2026 Earnings Call Transcript

Supernus (SUPN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Supernus Pharmaceuticals (SUPN) Beats Q1 Earnings and Revenue Estimates

Bausch Health (BHC) Lags Q1 Earnings Estimates

Biogen Beats Q1 Earnings Estimates but Cuts 2026 EPS View on M&A Costs

Biogen Walloped Wall Street's First Quarter Views; Here's What Happened

Biogen Q1 Earnings: Can New Launches Offset Declining MS Franchise?

수퍼너스, Barclays 컨퍼런스서 전략적 성장 및 미래 전망 제시

Supernus at Barclays Conference: Strategic Growth and Future Prospects

슈퍼너스, TD 코웬 컨퍼런스서 전략적 다각화 공개